Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest biopharmaceutical Stories

2013-10-01 04:22:37

New market insight uncovers the latest technology trends and strategic approaches for biopharma CMOs LONDON, Oct. 1, 2013 /PRNewswire/ -- Considerable growth opportunities lie ahead for biopharmaceutical contract manufacturing organisations (CMOs). With blockbuster biologics worth over $100 billion due to lose patent protection by 2019, the global biosimilars market is projected to grow at a robust compound annual growth rate (CAGR) of 60.4 percent between 2012 and 2019. A new...

2013-09-30 23:19:14

BioProcess International is dedicated to the application of biotechnology to industry, particularly to the development and manufacture of biopharmaceutical products including proteins, peptides, hormones, vaccines, gene therapies, cell and tissue therapies, and biodiagnostics. New York, NY (PRWEB) September 30, 2013 BioProcess International (BPI) announces the publication of the BioProcess International September 2013 issue featuring the following articles and special reports: Focus on...

2013-09-27 16:24:05

(all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON, Sept. 27, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its fiscal year ended June 30, 2013. "The Company is undergoing a significant transition," said Graeme McRae, President & CEO. "The pending divestment of the Animal Health business and potential sale or...

2013-09-25 08:30:03

HAYWARD, Calif., Sept. 25, 2013 /PRNewswire/ -- Anthera Pharmaceuticals (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that emerging data from its Phase 2b PEARL-SC study and subsequent Open-Label Extension study will be presented by Dr. Richard Furie at the 2013 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals...

2013-09-20 08:25:00

CHESTERBROOK, Pa., Sept. 20, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, today announced it entered into an Incremental Assumption Agreement ("Incremental Agreement") with Morgan Stanley Senior Funding, Inc. ("MSSF") under its existing Credit Agreement with MSSF. Under the Incremental Agreement, the Company raised an additional $50,000,000 from a syndicate of lenders, and this additional amount is on terms consistent with...

2013-09-19 16:26:25

LYNBROOK, N.Y., Sept. 19, 2013 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products marketed as XIAFLEX(®) in the U.S and XIAPEX(®) in the EU, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the Aegis Capital 2013 Healthcare Conference. The presentation will take place on Thursday, September 26, 2013 at 4:00 p.m. EDT (1:00 p.m. PDT) at the...

2013-09-19 08:27:59

ST. LOUIS, Sept. 19, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC(®) Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services business unit, has engineered additional traits into its CHOZN(® )Platform cell line,( )increasing the utility of the CHOZN(®) portfolio of products and services. Two novel host cell lines have been added to the CHOZN(®) portfolio, yielded through SAFC's continuous research and development. The...

2013-09-18 08:28:01

MONTPELLIER, France, September 18, 2013 /PRNewswire/ -- Online news publisher William Reed Business Media is delighted to announce the launch of BioPharma-Reporter.com, its third publication providing targeted daily news in the pharmaceutical sector. (Logo: http://photos.prnewswire.com/prnh/20130918/639259-a ) (Logo: http://photos.prnewswire.com/prnh/20130918/639259-b ) Bridging the gap in authoritative, independent and innovative online news...

2013-09-16 08:30:05

BOSTON, Sept. 16, 2013 /PRNewswire/ -- Benu BioPharma announced today the establishment of Benu BioVentures, a new biopharmaceutical investment initiative to fund and develop preclinical stage pharmaceutical investments to the human proof-of-concept stage. Leveraging Benu BioPharma's management expertise in technology commercialization and pharmaceutical development, Benu BioVentures is creating and financing virtual companies that will develop candidate drugs in a cost and time...

2013-09-12 12:29:09

PLANTATION, Fla., Sept. 12, 2013 /PRNewswire/ -- Goodwin Biotechnology, Inc. announced a key appointment that is designed to position the company for the future. SooYoung Lee, PhD has returned to Goodwin Biotechnology as Chief Operating Officer. He will report to newly appointed CEO, Karl Pinto, and will oversee all aspects of Goodwin's Contract Manufacturing Operations. SooYoung has had a distinguished career in the biological industry spanning several decades. After earning...